Mineralys Therapeutics(MLYS)
RADNOR, PABiotechnology
Focus: Mineralys Therapeutics is a public-stage biotechnology company headquartered in Radnor, PA, focused on small-molecule therapies for cardiovascular and nephrology indications. The company is advancing a pipeline centered on lorundrostat, with Phase 3 data emerging in hypertension and Phase 2 expansion into chronic kidney disease and obstructive sleep apnea.
Profile data last refreshed 12h ago · AI intelligence enriched 18h ago
Funding Stage
PUBLIC
Open Jobs
40+1 this month
Stable — net +1 jobs in 30d
45 added, 44 removed. Backfill posture.
Should You Work at Mineralys Therapeutics?
AI assessmentMineralys is a high-risk, high-reward mid-stage biotech best suited for early-career professionals or career-switchers seeking launch-phase intensity; incumbent pharma employees should assess personal risk tolerance around cash runway and Phase 3 gatekeepers.
Why Work Here
- Lorundrostat in Phase 3 for hypertension with recent Phase 2 CKD data showing 52% reduction in kidney damage marker—meaningful clinical validation in high-prevalence indications.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Lorundrostat
Obstructive Sleep ApneaClinical Trials (1)
NCT06785454A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension
Phase 2Help build intelligence for Mineralys Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.